SOX2 and Down syndrome: Apigenin shows a protective effect in the preclinical model of down syndrome, via reduction of oxidative stress and activation of proliferative and pro-neurogenic genes (KI7, Nestin, Sox2, and PAX6). Apigenin may be a potential therapeutic candidate for the management of down syndrome.